Quantitative and functional changes in platelets and fibrinogen following cardiopulmonary by-pass in children.

ROTEM cardiopulmonary bypass children coagulopathy congenital heart disease fibrinogen platelet

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2024
Historique:
received: 22 06 2024
accepted: 03 09 2024
medline: 2 10 2024
pubmed: 2 10 2024
entrez: 2 10 2024
Statut: epublish

Résumé

Cardiopulmonary bypass (CPB) causes coagulopathy, increasing the risk of postoperative bleeding and mortality. The underlying causes of post-CPB coagulopathy and the factors associated with its occurrence are not yet fully understood. This study assesses platelet and fibrinogen concentration and function following CPB in children with congenital heart diseases (CHD). We analyzed prospective data from 104 patients aged 0-16 years who underwent CPB surgery for CHD. Blood samples were collected before surgery and within 30 min of CPB completion. In addition to usual coagulation tests, functional analyses were performed using point of care systems with thromboelastometry and impedance aggregometry. Platelet count, fibrinogen concentration, and platelet and fibrinogen activities significantly decreased after CPB. The duration of CPB was directly associated with a reduction in platelet count and fibrinogen level ( Post-CPB coagulopathy is multifactorial and not solely attributed to hemodilution. It also involves functional changes in coagulation cascade components, which can be demonstrated by thromboelastometry and impedance aggregometry. Young children, patients requiring prolonged CPB surgery, or those experiencing hypothermia are particularly affected.

Identifiants

pubmed: 39355650
doi: 10.3389/fped.2024.1453182
pmc: PMC11443695
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1453182

Informations de copyright

© 2024 Plebani, Longchamp, Lauwers, Di Bernardo and Perez.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Margherita Plebani (M)

Pediatric Infectious Diseases and Vaccinology Unit, Department Women-Mother-Child, Lausanne University Hospital and University of Lausanne, Laussanne, Switzerland.

David Longchamp (D)

Pediatric Intensive Care Unit, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Laussanne, Switzerland.

Pauline Lauwers (P)

Pediatric Intensive Care Unit, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Laussanne, Switzerland.

Stefano Di Bernardo (S)

Pediatric Cardiology, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Laussanne, Switzerland.

Maria-Helena Perez (MH)

Pediatric Intensive Care Unit, Department Woman-Mother-Child, Lausanne University Hospital and University of Lausanne, Laussanne, Switzerland.

Classifications MeSH